Advanced Catheter Therapies
PrivateLast Round
Series B
Mar 17, 2015
Total Funding Raised
$7.72M
Company Overview
Advanced Catheter Therapies is a medical device company that develops and commercializes a portfolio of catheter technologies for treating vascular disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Advanced Catheter Therapies Comparables
Compare Advanced Catheter Therapies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Acrostak (Schweiz) AG | 84% | |
| Mercator MedSystems, Inc. | 83% | |
| Thrombolex, Inc. | 77% | |
Advanced Catheter Therapies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 17, 2015 | ||||
| Series A | Sep 29, 2011 | ||||
| Grant | Nov 5, 2010 |
Advanced Catheter Therapies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Chattanooga Renaissance Fund | Series B, Series A |
| Innova Memphis | Series B |
Advanced Catheter Therapies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Advanced Catheter Therapies's valuation, stock price, and market status.